About
Copy Link
Titles
Hospital Resident
Biography
Hometown: Kingsville, TX
Medical School: University of California San Francisco
Undergraduate: Harvard College
Professional Interests: Surgical oncology, Cancer research, Medical device/diagnostics.
Hobbies: Traveling abroad with my wife Shirley and son Oliver, Ballroom dancing, Running, Basketball
Last Updated on July 10, 2026.
Education & Training
- MD
- University of California San Francisco (2020)
- AB
- Harvard College, Chemical and Physical Biology (2014)
Research
Copy Link
Overview
Medical Research Interests
Artificial Intelligence; Consensus; Cytoreduction Surgical Procedures; Liver; Melanoma, Cutaneous Malignant; Neuroendocrine Tumors; Spatial Analysis; Surgical Oncology; Translational Science, Biomedical
Public Health Interests
Global Health
ORCID
0000-0002-8693-612X
Research at a Glance
Yale Co-Authors
Frequent collaborators of David Su's published research.
Publications Timeline
A big-picture view of David Su's research output by year.
Research Interests
Research topics David Su is interested in exploring.
Kiran Turaga, MD, MPH
Craig Gunderson, MD, SFHM
Harriet Kluger, MD
David Schoenfeld, MD, PhD
Elizabeth Godfrey, MD, MHS
Dijana Djureinovic, PhD, MSc
37Publications
284Citations
Consensus
Cytoreduction Surgical Procedures
Neuroendocrine Tumors
Publications
Featured Publications
SIMVI disentangles intrinsic and spatial-induced cellular states in spatial omics data
Dong M, Su D, Kluger H, Fan R, Kluger Y. SIMVI disentangles intrinsic and spatial-induced cellular states in spatial omics data. Nature Communications 2025, 16: 2990. PMID: 40148341, PMCID: PMC11950362, DOI: 10.1038/s41467-025-58089-7.Peer-Reviewed Original ResearchCitationsAltmetricReal-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma
Su D, McNamara M, Kaszycki M, Frey A, Ishizuka J, Costa P, Tran T, Kluger H, Clune J, Weiss S, Olino K. Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma. Surgical Oncology Insight 2025, 2: 100120. DOI: 10.1016/j.soi.2024.100120.Peer-Reviewed Original ResearchCitationsMutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy
Su D, Dhiman A, Bansal V, Zha Y, Shergill A, Polite B, Alpert L, Turaga K, Eng O. Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy. JCO Precision Oncology 2024, 8: e2400149. PMID: 39259912, PMCID: PMC11432692, DOI: 10.1200/po.24.00149.Peer-Reviewed Original ResearchCitationsAltmetricMelanocortin-1 Receptor Expression as a Marker of Progression in Melanoma
Su D, Djureinovic D, Schoenfeld D, Marquez-Nostra B, Olino K, Jilaveanu L, Kluger H. Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO Precision Oncology 2024, 8: e2300702. PMID: 38662983, PMCID: PMC11513442, DOI: 10.1200/po.23.00702.Peer-Reviewed Original ResearchCitationsAltmetricDigital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma
Su D, Schoenfeld D, Ibrahim W, Cabrejo R, Djureinovic D, Baumann R, Rimm D, Khan S, Halaban R, Kluger H, Olino K, Galan A, Clune J. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal For ImmunoTherapy Of Cancer 2024, 12: e008646. PMID: 38519058, PMCID: PMC10961546, DOI: 10.1136/jitc-2023-008646.Peer-Reviewed Original ResearchCitationsAltmetricEducational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma
Su D, Kluger H, Olino K. Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma. Annals Of Surgical Oncology 2023, 31: 1865-1879. PMID: 37989956, DOI: 10.1245/s10434-023-14587-w.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricPredicting the broadly neutralizing antibody susceptibility of the HIV reservoir
Yu W, Su D, Torabi J, Fennessey C, Shiakolas A, Lynch R, Chun T, Doria-Rose N, Alter G, Seaman M, Keele B, Lauffenburger D, Julg B. Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir. JCI Insight 2019, 4: e130153. PMID: 31484826, PMCID: PMC6777915, DOI: 10.1172/jci.insight.130153.Peer-Reviewed Original ResearchCitationsAltmetricProtective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys
Julg B, Sok D, Schmidt S, Abbink P, Newman R, Broge T, Linde C, Nkolola J, Le K, Su D, Torabi J, Pack M, Pegu A, Allen T, Mascola J, Burton D, Barouch D. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys. Journal Of Virology 2017, 91: 10.1128/jvi.01187-17. PMID: 28768869, PMCID: PMC5625479, DOI: 10.1128/jvi.01187-17.Peer-Reviewed Original ResearchCitationsAltmetricPalliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review
Xu M, Su D, Deboer R, Garcia M, Tahir P, Anderson W, Kinderman A, Braunstein S, Sherertz T. Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review. Journal Of Cancer Education 2017, 34: 205-215. PMID: 29264703, DOI: 10.1007/s13187-017-1310-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConsensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms
Su D, Brown L, Bansal V, Bakkila B, Concors S, Turaga K, Gunderson C, Bergsland E, Strosberg J, Halfdanarson T, Metz D, Kunstman J, Kunz P, Gangi A, Group P. Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Cancer 2025, 131: e35871. PMID: 40558053, DOI: 10.1002/cncr.35871.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity Advanced Cancer Therapies Organizing Committee
07/20/2023 - PresentMeeting Planning and ParticipationMemberactivity Society of Asian Academic Surgeons Communications Committee
08/01/2024 - PresentProfessional OrganizationsMemberactivity Society for Surgery of the Alimentary Tract Communications Committee
07/01/2024 - PresentProfessional OrganizationsMember
News
Copy Link
News
- March 09, 2026
Yale Cancer Center Experts Present Advances in Cancer Research at Major Surgical Meeting
- December 23, 2025Source: Memorial Sloan Kettering Cancer Center
New Consensus Guidelines for Colorectal and Appendiceal Peritoneal Metastases
- July 10, 2025
AI Outperforms People in Scoring Melanoma Tumor-Infiltrating Immune Cells
- June 27, 2025
Best Practices for Peritoneal Surface Malignancies: A Yale-Led National Expert Consensus
Get In Touch
Copy Link
Contacts
Email